GlassScriptPhysician profile
Joy G Johnson
NPI 1659324960
$3,279.42
in general payments reported to CMS, 2019-2025
13 companies · $578 in 2025
The $578 reported for 2025 was more than what 81% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,865 · 2021: $83.38 · 2022: $19.50 · 2023: $365 · 2024: $369 · 2025: $578.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,311.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,311.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,114.58 | 2019-2025 | Total30, Precision 1, Dailies Total1 |
| Tarsus Pharmaceuticals, INC. | $220.90 | 2024-2025 | Xdemvy |
| Bausch & Lomb Americas INC. | $184.04 | 2023-2025 | Vyzulta, Miebo |
| Glaukos Corporation | $174.13 | 2023 | |
| Mallinckrodt Hospital Products INC. | $122.02 | 2024 | Acthar |
| Abbvie INC. | $92.53 | 2024-2025 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $92.44 | 2019 | |
| Astellas Pharma US INC | $83.51 | 2024-2025 | Izervay |
| Johnson & Johnson Vision Care, INC. | $79.23 | 2025 | |
| Novartis Pharmaceuticals Corporation | $42.76 | 2022-2023 | |
| Ani Pharmaceuticals, INC. | $35.03 | 2025 | Purified Cortrophin Gel |
| Thea Pharma INC. | $19.16 | 2025 | Iyuzeh |
| Harrow Eye, LLC | $19.09 | 2024 | Natacyn, Vevye |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joy Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.